Table 2.
Reported reasons for exiting the LPV/r pellets pilot
| Reason for exit | Number of patients (%) | ART naïve | Switched from LPV/r syrup |
|---|---|---|---|
| Vomiting or not tolerating pellets | 14 (41.2) | 3 | 11 |
| Lost to follow‐up | 7 (20.6) | 0 | 7 |
| Transfer out | 5 (14.7) | 1 | 4 |
| Negative confirmatory HIV testa | 3 (8.8) | 1 | 2 |
| Other reason/unknownb | 3 (8.8) | 0 | 3 |
| Deceasedc | 2 (5.9) | 1 | 1 |
ART, antiretroviral therapy; LPV/r, lopinavir/ritonavir.
aChildren with an initial positive result through rapid testing that was later confirmed as negative through confirmatory DNA PCR testing; bcaregiver did not state the reason for exit as they were not obligated to, in line with ethical requirements of the pilot protocol; cthe causes of death for the two patients were: pneumonia and pulmonary tuberculosis for each child respectively. These were ruled as unrelated to the LPV/r oral pellets.